Skip to main content
editorial
. 2018 Jun 27;6(2):242–246. doi: 10.9745/GHSP-D-18-00206

TABLE 2.

HPV Testing Strengths and Limitations

HPV Testing Strengths HPV Testing Limitations
Point-of-care testing or centralized testing, dependent on testing platform and local needs Majority of HPV infections (especially in young women) are transientand clinically non-significant
Simplicity and potential scalability of self-collection of samples Lack of specificity for precancer
Reproducible results; not rater-dependent Higher per-capita tests costs than VIA
Economical due to longer screening intervals possible for HPV-negative women

Abbreviations: HPV, human papillomavirus; VIA, visual inspection with acetic acid.